Sponsor
Brighton and Sussex University Hospitals NHS Trust
Clinical research sponsor
Clinical trials
11 shownThe Medicines Optimisation Review Toolkit Evaluation in HIV OutpatientsNCT03340077 · lead sponsor · 2018-02-06
COMPLETEDPRISTINE - Personalised Approach to Improve aSThma prescrIbing iN childrEnNCT03269318 · lead sponsor · 2017-07-01
TERMINATEDImplementing Long-Acting Novel AntiretroviralsNCT05294159 · collaborator · 2022-07-18
COMPLETEDPatients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)NCT04901728 · collaborator · 2021-07-01
UNKNOWNA Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted TherapiesNCT04288141 · collaborator · 2019-12-20
UNKNOWNBeta-blockers for Oesophageal VaricesNCT03776955 · collaborator · 2019-06-17
UNKNOWNBeta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.NCT05872698 · collaborator · 2019-04-01
ACTIVE_NOT_RECRUITINGGenetic Determinants of Kidney Disease in People of African Ancestry With HIVNCT05685810 · collaborator · 2018-05-01
ACTIVE_NOT_RECRUITINGValidation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)NCT02904733 · collaborator · 2017-04-07
UNKNOWNResearch In Viral Eradication of HIV ReservoirsNCT02336074 · collaborator · 2015-11-27
COMPLETEDSingle Pulmonary Nodule InvestigationNCT02013063 · collaborator · 2012-08-01
UNKNOWNSponsor roles
collaborator9
lead sponsor2
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.